Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 4, 1996, Pages 1442-1447

  Faro, Albert ^a   Kurland, Geoffrey ^b   Michaels, Marian G ^b   Dickman, Paul S ^b   Greally, Peter G ^b   Spichty, Kathy J ^b   Noyes, Blakeslee B ^b   Boas, Steven R ^b   Fricker, F Jay ^b   Armitage, John M ^b   Zeevi, Adriana ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AZATHIOPRINE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; METHYLPREDNISOLONE; PREDNISONE; TACROLIMUS;

ARTICLE; CASE REPORT; CHILD; EPSTEIN BARR VIRUS; GENE EXPRESSION; GRAFT REJECTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY;

EID: 0029986126     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.4.8616579     Document Type: Article

References (23)

1. Hanto, D. W., K. J. Gajl-Peczalska, G. Frizzera, et al. 1983. Epstein-Barr virus (EBV) induced polyclonal and monclonal B-cell lymphoproliferative diseases occurring after renal transplantation: clinical, pathologic, and virologie findings and implications for therapy. Ann. Surg. 198:356-369.
2. Ho, M., G. Miller, R. W. Atchison, et al. 1985. Epstein-Barr virus infections and DNA hybridization studies in posttransplant lymphoma and lymphoproliferative lesions: the role of primary infection. J. Infect. Dis. 152:876-885.
3. Filipovich, A. H., R. S. Shapiro, L. Robinson, A. Mertens, and G. Frizzera. 1990. Lymphoproliferative disorders associated with immunodeficiency. In I. T. Magrath, editor. The Non-Hodgkin's Lymphomas, Vol. 9. Edward Arnold, London. 135.
4. Swinnen, L. J., M. R. Costanzo-Nordin, S. Fisher, et al. 1990. Increased incidence of lymphoproliferative disorder after immunosuppression with monoclonal antibody OKT3 in cardiac transplant recipients. N. Engl. J. Med. 323:1723.
5. Mathur, A., D. M. Kamat, A. H. Filipovich, M. Steinbuch, and R. S. Shapiro. 1994. Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders. Transplantation 57:1042-1045.
6. Nalesnik, M. A. 1991. Lymphoproliferative disease in organ transplant recipients. Springer Semin. Immunopathol. 13:199-216.
7. Ho, M., R. Jaffe, G. Miller, et al. 1988. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45:719-727.
8. Starzl, T. E., K. A. Porter, S. Iwatsuki, et al. 1984. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine steroid therapy. Lancet 1:583.
9. Hanto, D. W., G. Frizzera, K. J. Gajl-Peczalska, et al. 1985. Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative diseases. Transplant. Proc. 17:89-92.
10. Pirsch, J. D., R. J. Stratta, H. W. Sollinger, et al. 1989. Treatment of severe Eptsein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation. Am. J. Med. 86:241-244.
11. Fischer, A., S. Blanche, J. L. Bidois, et al. 1991. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N. Engl. J. Med. 324:1451-1456.
12. Shapiro, R. S., A. Chauvenet, W. McGuire, et al. 1988. Treatment of B cell lymphoproliferative disorder with interferon alpha and intravenous gamma globulin. N. Engl. J. Med. 318:1334.
13. Kurland, G., B. E. Noyes, R. Jaffe, et al. 1993. Bronchoalveolar lavage and transbronchial biopsy in children following heart-lung and lung transplantation. Chest 104:1043-1048.
14. Yousem, S. A., G. J. Berry, E. M. Brunt, et al. 1990. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. International Society for Heart Transplantation. J. Heart Transplant. 9:593-601.
15. Bleeker, E., E. McFadden, et al. 1991. Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J. Allergy Clin. Immunol. 88:808-814.
16. Rabinowich, H., A. Zeevi, I. L. Paradis, et al. 1990, Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 49:115.
17. Zeevi, A., C. Kaufman, and R. J. Duquesnoy. 1994. Clinical relevance of lymphocyte analysis in cardiac and pulmonary transplantation. In M. L. Rose and M. H. Yacoub, editors. Immunology of Heart and Lung Transplantation. Edward Arnold, London. 181-199.
18. Lee, E. S., J. Locker, M. Nalesnik, et al. 1995. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N. Engl. J. Med. 332:19-25.
19. Zeevi, A., J. H. Dauber, S. A. Yousem, et al. Immunologic alterations in chronic lung rejection. (In press)
20. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to differential functional properties. Annu. Rev. Immunol. 7:145.
21. Abbas, A., A. Lichtman, and J. Pober. 1994. Cytokines. In A. Abbas, A. Lichtman, and J. Pober, editors. Cellular and Molecular Immunology, 2nd ed. W. B. Saunders, Philadelphia. 240-260.
22. Biemer, J. J. 1990. Malignant lymphomas associated with immunodeficiency states. Ann. Clin. Lab. Sci. 20:175-191.
23. Nunley, D., J. Dauber, and A. lacono, et al. 1994. Ten year experience with post transplant lymphoproliferative disease following lung transplantation (abstract). Am. J. Respir. Crit. Care Med. 149:A731.